Management of perianal fistulas in Crohn’s disease: a 2021 update of the French National Society of Coloproctology consensus
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Surgery
Link
https://link.springer.com/content/pdf/10.1007/s10151-022-02678-x.pdf
Reference16 articles.
1. Bouchard D, Pigot F, Staumont G, Siproudhis L, Abramowitz L, Benfredj P et al (2018) Management of anoperineal lesions in Crohn’s disease: a French National Society of Coloproctology national consensus. Tech Coloproctol 22:905–917
2. Hommes D, Colombel JF, Emery P, Greco M, Sandborn WJ (2012) Changing Crohn’s disease management: need for new goals and indices to prevent disability and improve quality of life. J Crohns Colitis 6(Suppl2):S224–S234
3. Irvine EJ (1995) Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index McMaster IBD Study Group. J Clin Gastroenterol 20:27–32
4. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA et al (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398–1405
5. Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC et al (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised double-blind controlled trial. Lancet 388:1281–1290
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Allogenic stem cells for Crohn's anal fistulas: Treating early improves the deep remission rate;Colorectal Disease;2023-10-17
2. Allogenic stem cells for anal Crohn’s fistula: treating early improves the deep response rate;2023-02-27
3. Deep remission improves the quality of life of patients with Crohn’s disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study;Techniques in Coloproctology;2023-02-22
4. Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021;Journal of Gastroenterology;2023-02-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3